|
|
|
|
Inhibits enzymes involved in
formation of peptidoglycan layer of bacterial cell wall No effect on human cell walls Bactericidal; only works on dividing bacteria More resistant than 1st generation to ß-lactamases More effective against Gram -ves than 2nd generation, but less active against S. aureus Good tissue distribution, including bone, soft tissue and muscle 3rd generation cephalosporin |
|
|
1 hour |
|
|
Rapid clearance from plasma due to active secretion into renal tubular fluid - can be blocked by probenecid; forms desacetyl metabolite |
|
|
Infections due to sensitive
Gram +ve and Gram -ve bacteria Soft tissue infections e.g. S. pyogenes S. pneumoniae, M. catarrhalis, H. influenzae including community aquired pneumonia Also active against E. coli - urinary tract (inc. pyelonephritis) and abdominal infections Enterobacteriaceae Meningitis e.g. H. influenzae Septicaemia Surgical prophylaxis |
|
These may be out of date or wrong. |
i.m./i.v. 1g
every 12 hours Meningitis - 8g i.v. daily in 4 divided doses |
|
|
Allergic reactions Diarrhoea, nausea and vomiting |
|
|
Loop diuretics may increase
nephrotoxicity Uricosurics - probenecid reduces excretion May increase anticoagulant effect of warfarin |
|
|
Penicillin hypersensitivity Renal impairment Pregnancy and breast feeding (still OK to use) False positive urinary glucose False positive Coomb's test |
|
|
Cephalosporin hypersensitivity Porphyria |